Brainstorm Cell Therapeutics Inc. (BCLI)
NASDAQ: BCLI · Real-Time Price · USD
1.800
-0.060 (-3.23%)
Nov 4, 2024, 4:00 PM EST - Market closed
BCLI Employees
Brainstorm Cell Therapeutics had 29 employees as of December 31, 2023. The number of employees decreased by 14 or -32.56% compared to the previous year.
Employees
29
Change (1Y)
-14
Growth (1Y)
-32.56%
Revenue / Employee
n/a
Profits / Employee
-$439,517
Market Cap
9.57M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Mustang Bio | 80 |
NKGen Biotech | 63 |
RedHill Biopharma | 53 |
Jaguar Health | 49 |
Senti Biosciences | 48 |
Addex Therapeutics | 23 |
Edesa Biotech | 16 |
Alterity Therapeutics | 10 |
BCLI News
- 5 days ago - BrainStorm Cell Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement - PRNewsWire
- 7 days ago - BrainStorm Cell Therapeutics Presented Positive Survival Data from NurOwn® Expanded Access Program at 2024 Annual NEALS Meeting - PRNewsWire
- 4 weeks ago - BrainStorm Cell Therapeutics to Provide Corporate Update on Phase 3b NurOwn® Trial at the 2024 Maxim Healthcare Virtual Summit - PRNewsWire
- 5 weeks ago - BrainStorm Cell Therapeutics Announces Presentations on NurOwn® at 2024 Annual NEALS Meeting - PRNewsWire
- 2 months ago - Brainstorm Cell Therapeutics Inc. (BCLI) Q2 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - BrainStorm Cell Therapeutics Announces Second Quarter 2024 Financial Results and Provides Corporate Update - PRNewsWire
- 3 months ago - BrainStorm Cell Therapeutics to Announce Second Quarter Results and Provide a Corporate Update - PRNewsWire
- 3 months ago - BCLI Update - Progress Supports Our 10x Plus Value Range Potential - PRNewsWire